Table 2.

Baseline characteristics: genetics per the presence of del

No del, n (%)del, n (%)
Del(17p) 15 (36.6) 26 (63.4) 
From >7.45%to 20%  5 (12.2) 
>20% — 21 (51.2) 
No del, n (%)del, n (%)
Del(17p) 15 (36.6) 26 (63.4) 
From >7.45%to 20%  5 (12.2) 
>20% — 21 (51.2) 
Unmutated, n (%)Mutated, n (%)
TP53 2 (4.9) 39 (95.1) 
 35 (85.4) 
>1 4 (9.8) 
NOTCH1 38 (92.7) 3 (7.3) 
SF3B1 34 (82.9) 7 (17.1) 
IGHV  32 (78.0) 6 (14.6) 
Unmutated, n (%)Mutated, n (%)
TP53 2 (4.9) 39 (95.1) 
 35 (85.4) 
>1 4 (9.8) 
NOTCH1 38 (92.7) 3 (7.3) 
SF3B1 34 (82.9) 7 (17.1) 
IGHV  32 (78.0) 6 (14.6) 
Noncomplex, n (%)Complex, n (%)
Karyotype  15 (38.5) 24 (61.5) 
Noncomplex, n (%)Complex, n (%)
Karyotype  15 (38.5) 24 (61.5) 

IGHV: 3 patients were not evaluable.

Karyotype: 2 patients were not evaluable.

or Create an Account

Close Modal
Close Modal